Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs

Binaschi, 1995, Mechanism of action of DNA topoisomerase inhibitors, Stem Cells, 13, 369, 10.1002/stem.5530130408 Blount, 2006, Riboswitches as antibacterial drug targets, Nat. Biotechnol., 24, 1558, 10.1038/nbt1268 Bose, 2012, The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor, Angew. Chem. Int. Ed., 51, 1019, 10.1002/anie.201106455 Calin, 2006, MicroRNA-cancer connection: the beginning of a new tale, Cancer Res., 66, 7390, 10.1158/0008-5472.CAN-06-0800 Carter, 2000, Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics, Nature, 407, 340, 10.1038/35030019 Chan, 2005, MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells, Cancer Res., 65, 6029, 10.1158/0008-5472.CAN-05-0137 Childs-Disney, 2007, A small molecule microarray platform to select RNA internal loop-ligand interactions, ACS Chem. Biol., 2, 745, 10.1021/cb700174r Childs-Disney, 2014, Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity, ACS Chem. Biol., 9, 538, 10.1021/cb4007387 Chirayil, 2014, NMR characterization of an oligonucleotide model of the miR-21 pre-element, PLoS One, 9, e108231, 10.1371/journal.pone.0108231 Connelly, 2017, Discovery of inhibitors of microRNA-21 processing using small molecule microarrays, ACS Chem. Biol., 12, 435, 10.1021/acschembio.6b00945 Cooper, 2009, RNA and disease, Cell, 136, 777, 10.1016/j.cell.2009.02.011 Cserép, 2014, Fluorogenic tagging of peptides via Cys residues using thiol-specific vinyl sulfone affinity tags, Tetrahedron, 70, 5961, 10.1016/j.tet.2014.05.103 Dibrov, 2014, Hepatitis C virus translation inhibitors targeting the internal ribosomal entry site, J. Med. Chem., 57, 1694, 10.1021/jm401312n Disney, 2008, Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners, J. Am. Chem. Soc., 130, 11185, 10.1021/ja803234t 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 Feofanov, 1997, Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis, Biophys. J., 73, 3317, 10.1016/S0006-3495(97)78356-5 Frazier, 2015, Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective, Toxicol. Pathol., 43, 78, 10.1177/0192623314551840 Gareiss, 2008, Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1), J. Am. Chem. Soc., 130, 16254, 10.1021/ja804398y Guan, 2013, Covalent small molecule-RNA complex formation enables cellular profiling of small molecule-RNA interactions, Angew. Chem. Int. Ed., 52, 10010, 10.1002/anie.201301639 Gumireddy, 2008, Small molecule inhibitors of microRNA miR-21 function, Angew. Chem. Int. Ed., 47, 7482, 10.1002/anie.200801555 Hajihassan, 2011, The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: selective release of histone proteins, Indian J. Pharmacol., 43, 187, 10.4103/0253-7613.77362 Hampf, 2006, A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays, Anal. Biochem., 356, 94, 10.1016/j.ab.2006.04.046 Hergenrother, 2000, Small-molecule microarrays: covalent attachment and screening of alcohol-containing small molecules on glass slides, J. Am. Chem. Soc., 122, 7849, 10.1021/ja0014032 Huang, 2009, Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion, J. Biol. Chem., 284, 18515, 10.1074/jbc.M109.006676 Ivanov, 1998, Cisplatin binding sites on human albumin, J. Biol. Chem., 273, 14721, 10.1074/jbc.273.24.14721 Jahromi, 2013, A novel CUGexp·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1, ACS Chem. Biol., 8, 1037, 10.1021/cb400046u Kumar, 2012, Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts, ACS Chem. Biol., 7, 496, 10.1021/cb200413a Lee, 2009, Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression, RNA Biol., 6, 187, 10.4161/rna.6.2.7727 Lee, 2014, A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication, Chem. Commun. (Camb.), 50, 368, 10.1039/C3CC46973E Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 Liang, 2015, Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages, Nucleic Acids Res., 43, 2927, 10.1093/nar/gkv143 Liu, 2009, Mitoxantrone analogues as ligands for a stem-loop structure of tau pre-mRNA, J. Med. Chem., 52, 6523, 10.1021/jm9013407 Liu, 2016, Analysis of secondary structural elements in human microRNA hairpin precursors, BMC Bioinformatics, 17, 112, 10.1186/s12859-016-0960-6 Lown, 1984, Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy, Mol. Pharmacol., 25, 178 MacBeath, 2000, Printing proteins as microarrays for high-throughput function determination, Science, 289, 1760, 10.1126/science.289.5485.1760 MacBeath, 1999, Printing small molecules as microarrays and detecting protein-ligand interactions en masse, J. Am. Chem. Soc., 121, 7967, 10.1021/ja991083q Mansour, 2010, New anthracenedione derivatives with improved biological activity by virtue of stable drug-DNA adduct formation, J. Med. Chem., 53, 6851, 10.1021/jm901894c Marcheschi, 2009, Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA, ACS Chem. Biol., 4, 844, 10.1021/cb900167m McConnell, 2010, Calix[4]arene-based rotaxane host systems for anion recognition, Chemistry, 16, 1256, 10.1002/chem.200902659 Mei, 1995, Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics, Bioorg. Med. Chem. Lett., 5, 2755, 10.1016/0960-894X(95)00467-8 Meng, 2007, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, Gastroenterology, 133, 647, 10.1053/j.gastro.2007.05.022 Moon, 2018, Measuring RNA-ligand interactions with microscale thermophoresis, Biochemistry, 10.1021/acs.biochem.7b01141 Morrow, 2017, New therapy for spinal muscular atrophy offers modest bang for pharamaceutical buck, Manag. Care, 26, 36 Naro, 2015, Aryl amide small-molecule inhibitors of microRNA miR-21 function, Bioorg. Med. Chem. Lett., 25, 4793, 10.1016/j.bmcl.2015.07.016 Naryshkin, 2014, Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy, Science, 345, 688, 10.1126/science.1250127 O'Donnell, 2005, c-Myc-regulated microRNAs modulate E2F1 expression, Nature, 435, 839, 10.1038/nature03677 Palacino, 2015, SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice, Nat. Chem. Biol., 11, 511, 10.1038/nchembio.1837 Panwar, 2017, miRmine: a database of human miRNA expression profiles, Bioinformatics, 33, 1554, 10.1093/bioinformatics/btx019 Pilch, 2003, Characteristics of γ-H2AX foci at DNA double-strand breaks sites, Biochem. Cell Biol., 81, 123, 10.1139/o03-042 Poehlsgaard, 2005, The bacterial ribosome as a target for antibiotics, Nat. Rev. Microbiol., 3, 870, 10.1038/nrmicro1265 Pushechnikov, 2009, Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3, J. Am. Chem. Soc., 131, 9767, 10.1021/ja9020149 du Rieu, 2010, MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions, Clin. Chem., 56, 603, 10.1373/clinchem.2009.137364 Rogakou, 1999, Megabase chromatin domains involved in DNA double-strand breaks in vivo, J. Cell Biol., 146, 905, 10.1083/jcb.146.5.905 Rzuczek, 2015, Studying a drug-like, RNA-focused small molecule library identifies compounds that inhibit RNA toxicity in myotonic dystrophy, ACS Chem. Biol., 10, 2706, 10.1021/acschembio.5b00430 Rzuczek, 2017, Precise small-molecule recognition of a toxic CUG RNA repeat expansion, Nat. Chem. Biol., 13, 188, 10.1038/nchembio.2251 Seidel, 2013, Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions, Methods, 59, 301, 10.1016/j.ymeth.2012.12.005 Seike, 2009, MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers, Proc. Natl. Acad. Sci. USA, 106, 12085, 10.1073/pnas.0905234106 Shaul, 2013, The structure of anthracycline derivatives determines their subcellular localization and cytotoxic activity, ACS Med. Chem. Lett., 4, 323, 10.1021/ml3002852 Shortridge, 2015, Structure based approaches for targeting non-coding RNAs with small molecules, Curr. Opin. Struct. Biol., 30, 79, 10.1016/j.sbi.2015.01.008 Shortridge, 2017, A macrocyclic peptide ligand binds the oncogenic microRNA-21 precursor and suppresses dicer processing, ACS Chem. Biol., 12, 1611, 10.1021/acschembio.7b00180 Su, 2014, Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS, Neuron, 84, 239, 10.1016/j.neuron.2014.09.019 Swift, 2006, Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death, Cancer Res., 66, 4863, 10.1158/0008-5472.CAN-05-3410 Tenson, 2006, Antibiotics and the ribosome, Mol. Microbiol., 59, 1664, 10.1111/j.1365-2958.2006.05063.x Velagapudi, 2014, Sequence-based design of bioactive small molecules that target precursor microRNAs, Nat. Chem. Biol., 10, 291, 10.1038/nchembio.1452 Velagapudi, 2017, Defining RNA-small molecule affinity landscapes enables design of a small molecule inhibitor of an oncogenic noncoding RNA, ACS Cent. Sci., 3, 205, 10.1021/acscentsci.7b00009 Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc. Natl. Acad. Sci. USA, 103, 2257, 10.1073/pnas.0510565103 Yan, 2008, MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis, RNA, 14, 2348, 10.1261/rna.1034808 Yang, 2015, Inhibition of non-ATG translational events in cells via covalent small molecules targeting RNA, J. Am. Chem. Soc., 137, 5336, 10.1021/ja507448y Yang, 2016, Small molecule recognition and tools to study modulation of r(CGG)(exp) in fragile X-associated tremor ataxia syndrome, ACS Chem. Biol., 11, 2456, 10.1021/acschembio.6b00147 Zapp, 1993, Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production, Cell, 74, 969, 10.1016/0092-8674(93)90720-B Zheng, 2009, Structural basis for stabilization of the Tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone), Chem. Biol., 16, 557, 10.1016/j.chembiol.2009.03.009 Zhu, 2008, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis, Cell Res., 18, 350, 10.1038/cr.2008.24